ArticlePrzeglad gastroenterologiczny2025

Evaluation of the clinical utility of measuring serum infliximab and vedolizumab concentrations during monitoring of biologic therapy in patients with inflammatory bowel disease.

Beata Kotowicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.